New Antifungal Drugs, New Approaches and Vaccines

Arno Therapeutics to Present Data on Trans-Fungal Delivery of AR-12 at 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Exposition

15 July 2016

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

13 June 2016

SCYNEXIS, Inc. Receives Orphan Drug Designation For SCY-078 For The Treatment Of Invasive Candida Infections

13 May 2016

Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

Phase 2

19 January 2016

Study of Potential for Interaction of Fluconazole With F901318

Phase 1

20 May 2016

Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects (ORALMAD)

Phase 1

23 March 2016

RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections

Phase 2

28 March 2016

STRIVE: CD101 Compared to Caspofungin Followed by Oral Step Down Treatment in Subjects With Candidemia

Phase 2

16 March 2016

Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% (OPEN)

Phase 4

20 May 2016

Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer (LOOP)

Phase 4

20 May 2016